GSK · story · 24 October – 27 October
GSK · 4 headlines from 3 outlets, from 24 October 2026 to 27 October 2026.
GSK results are scheduled for 28 October and listed in week-ahead previews.
The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.
TradingView is the largest at 3.8, 11.4 times AD HOC NEWS (0.3). Interactive Investor is the smallest at 0.0.
Source: MarketFrame news analysis
| outlet | Average tone |
|---|---|
| TradingView | 3.8 |
| AD HOC NEWS | 0.3 |
| Interactive Investor | 0.0 |
| Outlet | Headlines | Average tone |
|---|---|---|
| TradingView | 2 | +3.8 |
| AD HOC NEWS | 1 | +0.3 |
| Interactive Investor | 1 | 0.0 |
One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.
| Tone | What the article reported, and why it scored that way |
|---|---|
| +6.7 | Summary of ovarian trial response rate and results. |
| +0.8 | Routine earnings expectations preview. |
| Tone | What the article reported, and why it scored that way |
|---|---|
| +0.3 | Factual announcement of third-quarter results date. |
| 0.0 | Preview of upcoming results; neutral. |
A short, free morning email on how the news treated GSK: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.